| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0022 | 1 |